Trellus Health Deploys TrialSet for Takeda’s Mid-Stage Immunology Trial
Trellus Health is deploying its TrialSet platform with ICON plc across multiple agreed-upon sites for Takeda’s mid-stage immunology and inflammation clinical trial, with implementation slated to begin mid-second quarter. This operational partnership aims to streamline trial execution and support Takeda’s immunology pipeline.
1. TrialSet Deployment for Takeda Immunology Trial
Trellus Health has initiated deployment of its TrialSet platform with ICON plc across multiple agreed-upon sites for a mid-stage immunology and inflammation clinical trial sponsored by Takeda. Implementation is scheduled to commence in mid-second quarter, reflecting Trellus’s aim to enhance operational efficiency and support Takeda’s immunology pipeline.
Related News
CRM
Salesforce Faces Competition from Nvidia’s $200B AI CPU, Nasdaq Rally
CRM•
AAPL
Apple App Store Blocks 1 Billion Fake Accounts, Prevents $2.2B Fraud
AAPL•
FIVE
Five Below to Release Q1 Results June 3; 1,900+ Store Expansion Driving Growth
FIVE•
VBCF
Vanguard’s BondBuilder ETFs Garner $242M, Join $70B Target Maturity Market
VBCF•
T
AT&T Commits $19 B to California Fiber and 1,200 New Cell Sites by 2030
T•
Sources
F